The German Cannabisgesetz (CanG) of 27 March 2024 defines natural cannabis in KCanG §1(8) as plant parts and resin including cannabinoids, excluding CBD and Nutzhanf, and permits adults to possess up to 25 grams in public or 50 grams at home and cultivate up to three living plants under KCanG §§2-3.
Hemi-synthetic THC isomers such as Delta-8-THC and Delta-10-THC are not explicitly termed as such but are listed in BtMG Anlage I as amended by CanG Article 3, remaining under narcotics control unless they occur in non-synthetic form for non-medical purposes. The legal distinction hinges on whether a THC isomer occurs naturally in the cannabis plant or is produced synthetically. Under the amended Annex I of the Narcotics Act (BtMG), isomers such as Delta‑8‑THC and Delta‑10‑THC are listed as controlled narcotics, but the annex explicitly exempts “a non‑synthetic form that is placed on the market for non‑medical purposes.” A non‑synthetic form means the isomer is present as a natural constituent of the cannabis plant, for example as a trace component in flowers or leaves. When such naturally occurring isomers remain in the plant material, they fall outside the BtMG and instead are governed by the Consumer Cannabis Act (KCanG), which permits adults to possess and cultivate cannabis with all its natural cannabinoids within the specified quantity limits. However, the exemption does not apply if the isomer is produced synthetically or hemi‑synthetically, i.e., through chemical conversion from another cannabinoid like cannabidiol (CBD). Such artificially created Delta‑8‑THC or Delta‑10‑THC remains fully subject to BtMG controls, including criminal penalties, regardless of the legalisation of natural cannabis. German law thus draws a clear line: plant‑derived THC isomers benefit from the new legal framework for consumer cannabis, whereas chemically modified versions stay classified as high‑risk narcotics.
Synthetic cannabimimetics fall outside the CanG’s scope and are governed by the Neue-psychoaktive-Stoffe-Gesetz (NpSG). The extraction of cannabinoids from the cannabis plant is generally forbidden under KCanG §2(2), with only two exceptions: extraction of CBD and extraction required for analytical testing under KCanG §21(2) sentence 2 numbers 5 and 6. Medical and medical-scientific cannabis, including synthetic Dronabinol and defined THC isomers for scientific use, is regulated separately by the Medizinal-Cannabisgesetz (MedCanG) §§2-4, requiring a permit from the Bundesinstitut für Arzneimittel und Medizinprodukte.






